{"id":"https://openalex.org/W2977626525","doi":"https://doi.org/10.14309/00000434-201110002-01095","title":"Infliximab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety","display_name":"Infliximab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety","publication_year":2011,"publication_date":"2011-10-01","ids":{"openalex":"https://openalex.org/W2977626525","doi":"https://doi.org/10.14309/00000434-201110002-01095","mag":"2977626525"},"language":"en","primary_location":{"id":"doi:10.14309/00000434-201110002-01095","doi":"https://doi.org/10.14309/00000434-201110002-01095","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-201110002-01095","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001585119","display_name":"J. McGowen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. McGowen","raw_affiliation_strings":["Centocor Ortho Biotech Services, LLC, Horsham, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Ortho Biotech Services, LLC, Horsham, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064356639","display_name":"L. Brajdic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Brajdic","raw_affiliation_strings":["Centocor Ortho Biotech Services, LLC, Horsham, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Ortho Biotech Services, LLC, Horsham, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050925901","display_name":"Shivani Anil Patel","orcid":"https://orcid.org/0000-0003-0082-5857","observed_orcids":["https://orcid.org/0000-0003-0082-5857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Patel","raw_affiliation_strings":["Centocor Ortho Biotech Services, LLC, Horsham, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Ortho Biotech Services, LLC, Horsham, PA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054639647","display_name":"Brenda J. Sarokhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Sarokhan","raw_affiliation_strings":["Centocor Ortho Biotech Services, LLC, Horsham, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Ortho Biotech Services, LLC, Horsham, PA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23107138,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"106","issue":null,"first_page":"S408","last_page":"S408"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/risk-evaluation-and-mitigation-strategy","display_name":"risk evaluation and mitigation strategy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8169999718666077},{"id":"https://openalex.org/keywords/histoplasmosis","display_name":"histoplasmosis","score":0.9380000233650208},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tuberculosis-reactivation","display_name":"tuberculosis reactivation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prescriber-education","display_name":"prescriber education","score":0.492000013589859},{"id":"https://openalex.org/keywords/medication-guides","display_name":"medication guides","score":0.5},{"id":"https://openalex.org/keywords/gastroenterologists","display_name":"gastroenterologists","score":0.6019999980926514},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5440000295639038},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9332860708236694},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7443181872367859},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.4855758547782898},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48542484641075134},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.408452570438385},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.3429434299468994},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.22207427024841309},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17300641536712646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17090639472007751},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/00000434-201110002-01095","doi":"https://doi.org/10.14309/00000434-201110002-01095","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-201110002-01095","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3158677318","https://openalex.org/W2559699774","https://openalex.org/W3190973728","https://openalex.org/W128261037","https://openalex.org/W2140819610","https://openalex.org/W7206173927","https://openalex.org/W3007008949","https://openalex.org/W2583891203","https://openalex.org/W4391969002","https://openalex.org/W2140559939"],"abstract_inverted_index":{"Purpose:":[0],"Programs":[1],"referred":[2],"to":[3,14,49,69,99,105,127,213,243,310,390,415,421],"as":[4,261,389],"Risk":[5,353],"Evaluation":[6],"and":[7,20,54,73,160,170,182,194,216,237,250,276,285,305,313,318,372,378,411,419],"Mitigation":[8],"Strategies":[9],"(REMS)":[10],"have":[11,234],"been":[12,326],"implemented":[13],"assess":[15,50],"the":[16,41,52,57,76,82,130,133,139,142,150,155,162,199,214,223,227,232,256,264,291,342,374,408,412,431],"risk":[17,112],"with":[18,28,114,149,165,188,203,258,394],"drug":[19,116,134],"biologic":[21],"therapies.":[22],"Prescriber":[23],"assessment":[24,84,344,428],"of":[25,65,75,132,141,178,222,231,255,290,297,336,364,366,373,376,487],"risks":[26,140,163,201,392],"awareness":[27],"a":[29,101,107,115,123,271,277,298],"medication":[30,272,417],"can":[31,404],"be":[32,241,405],"done":[33],"through":[34],"third":[35],"party":[36],"web-based":[37],"surveys":[38],"in":[39,46,154,226,332],"which":[40],"resultant":[42],"data":[43,72,355,429],"are":[44,330],"analyzed":[45],"aggregate":[47],"form":[48],"if":[51,119],"communication":[53,274,294],"education":[55],"surrounding":[56],"REMS":[58,79,102,124,146,209,233,269,293,398,433,488],"is":[59,68,125,211,399,434],"meeting":[60,435],"its":[61,436],"goal.":[62],"The":[63,88,144,267,288,425],"purpose":[64],"this":[66],"study":[67,477],"provide":[70],"prescriber":[71,343],"outcome":[74],"infliximab":[77],"(IFX)":[78],"program":[80,210],"at":[81,238,245],"18-month":[83,427],"time":[85,235],"period.":[86],"Methods:":[87],"FDA":[89,244],"may":[90,217],"now":[91],"require":[92],"manufacturers":[93],"like":[94],"Centocor":[95,442,449,456,463,481],"Ortho":[96,443,450,457,464,482],"Biotech":[97,444,451,458,465,483],"Inc.":[98],"implement":[100],"(a":[103],"strategy":[104],"manage":[106],"known":[108],"or":[109,117,135,220],"potential":[110],"serious":[111,200],"associated":[113,164,187,202,393],"biologic),":[118],"they":[120],"determine":[121],"that":[122,129,357,403],"necessary":[126],"ensure":[128],"benefits":[131],"biological":[136],"product":[137,215],"outweigh":[138],"medication.":[143],"IFX":[145,166,204,268,292,348,426,432],"was":[147,469,478],"required":[148,262],"following":[151],"goals":[152],"outlined":[153],"approved":[156],"REMS:":[157],"To":[158],"communicate":[159],"mitigate":[161],"by:":[167],"1.":[168],"Alerting":[169],"warning":[171],"health":[172],"care":[173],"providers":[174],"(HCPs)":[175],"about":[176,198],"cases":[177],"unrecognized":[179],"histoplasmosis":[180],"(Histo)":[181],"other":[183,320,379],"invasive":[184,380],"fungal":[185,381],"infections":[186,382],"Tumor":[189],"Necrosis":[190],"Factor":[191],"(TNF)":[192],"blockers;":[193],"2.":[195],"Educating":[196],"patients":[197],"therapy.":[205],"An":[206],"individual":[207],"medication's":[208],"unique":[212],"include":[218,341],"one":[219],"more":[221],"elements":[224],"listed":[225],"table":[228],"below.":[229],"Assessments":[230],"tables":[236],"minimum":[239],"must":[240],"submitted":[242],"18":[246],"months,":[247,282],"3":[248,283],"years,":[249],"7":[251,286],"years":[252,284],"after":[253],"approval":[254],"strategy,":[257],"additional":[259],"assessments":[260,280],"by":[263,407,471,480],"FDA.":[265],"Results:":[266],"includes":[270],"guide,":[273],"plan":[275,295],"timetable":[278],"for":[279,346],"(18":[281],"years).":[287],"implementation":[289],"consisting":[296],"Dear":[299],"Health":[300],"Care":[301],"Professional":[302],"Letter":[303],"(DHCPL)":[304],"Serious":[306],"Infection":[307],"Guide":[308],"disseminated":[309],">13,800":[311],"adult":[312],"pediatric":[314],"gastroenterologists":[315],"(GEs)":[316],"combined":[317],">356,000":[319],"HCPs,":[321],"including":[322],"infusion":[323],"centers":[324],"has":[325],"executed.":[327],"Medication":[328],"Guides":[329],"included":[331],"each":[333],"dispensed":[334],"vial":[335],"IFX.":[337,396],"Data":[338],"presented":[339],"will":[340],"findings":[345],"415":[347],"prescribers":[349,360],"(gastroenterology":[350],"subspecialty,":[351],"n=211).":[352],"survey":[354],"indicate":[356,430],"nearly":[358],"all":[359],"surveyed":[361],"were":[362],"aware":[363],"re-activation":[365],"TB":[367],"(97%":[368],"[GEs":[369,384],"n=211,":[370],"98%])":[371],"development":[375],"Histo":[377],"(91%":[383],"n=96,":[385],"90%])":[386],"when":[387],"questioned":[388],"possible":[391],"taking":[395],"Conclusion:":[397],"an":[400,472],"important":[401],"tool":[402],"used":[406],"FDA,":[409],"HCPs":[410],"pharmaceutical":[413],"industry":[414,473],"improve":[416],"safety":[418],"access":[420],"efficacious":[422],"treatment":[423],"options.":[424],"goals.":[437],"Disclosure:":[438],"JR":[439],"McGowen:":[440],"Employee,":[441,448,455,462],"Services;":[445,452,459],"L":[446],"Brajdic:":[447],"B":[453],"Sarokhan:":[454],"S":[460],"Patel:":[461],"Services.":[466],"This":[467,476],"research":[468],"supported":[470],"grant":[474],"from":[475],"sponsored":[479],"Services,":[484],"LLC.Table:":[485],"Elements":[486]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2019-10-10T00:00:00"}